Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 21, 2017; 23(43): 7735-7745
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7735
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7735
Figure 3 Patient selection and cohorting.
MPVTT: Main portal vein tumor thrombus; HCC: Hepatocellular carcinoma; TACE: Transarterial chemoembolization; EVBT: Endovascular brachytherapy.
- Citation: Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol 2017; 23(43): 7735-7745
- URL: https://www.wjgnet.com/1007-9327/full/v23/i43/7735.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i43.7735